Grants and Contributions

The “Catalyst Grant: Addressing Musculoskeletal Conditions and Arthritis in Canadians” is expected to:

• Support original, high quality projects that have the potential to generate innovative research, research tools, techniques, devices, inventions, or methods that will translate into a clinical or health services improvement for Canadians within 5-7 years;
• Facilitate team formation and build patient-oriented research capacity by encouraging partnerships amongst patients, patient communities, patient organizations and health charities, researchers, health care professionals and health system decision makers or policy makers;
• Generate preliminary observations, data or knowledge to stimulate research in areas where there is a substantial burden of disease in musculoskeletal conditions and arthritis in Canada, as identified by the respective communities.

The specific objectives of this funding opportunity are to:
1.Provide women’s health researchers and trainees with operating funds to perform clinical research;
2.Support capacity building in women’s health among the next generation of health researchers; and
3.Start positioning Canada as a leader in women’s health research.

• The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined to be relevant to the mandate and research priority areas of CIHR-IMHA as described below:
o Musculoskeletal Health (arthritis, musculoskeletal rehabilitation, bone, skeletal muscle)

The specific objectives of this funding opportunity are to:
1.Provide women’s health researchers and trainees with operating funds to perform clinical research;
2.Support capacity building in women’s health among the next generation of health researchers; and
3.Start positioning Canada as a leader in women’s health research.

The “Catalyst Grant: Addressing Musculoskeletal Conditions and Arthritis in Canadians” is expected to:

• Support original, high quality projects that have the potential to generate innovative research, research tools, techniques, devices, inventions, or methods that will translate into a clinical or health services improvement for Canadians within 5-7 years;
• Facilitate team formation and build patient-oriented research capacity by encouraging partnerships amongst patients, patient communities, patient organizations and health charities, researchers, health care professionals and health system decision makers or policy makers;
• Generate preliminary observations, data or knowledge to stimulate research in areas where there is a substantial burden of disease in musculoskeletal conditions and arthritis in Canada, as identified by the respective communities.

.
• Support knowledge translation to inform practice, clinical care, policy, and/or decision making.
• Build and support partnerships between researchers and health system decision makers.

The “Catalyst Grant: Addressing Musculoskeletal Conditions and Arthritis in Canadians” is expected to:
•Support original, high quality projects that have the potential to generate innovative research, research tools, techniques, devices, inventions, or methods that will translate into a clinical or health services improvement for Canadians within 5-7 years;
•Facilitate team formation and build patient-oriented research capacity by encouraging partnerships amongst patients, patient communities, patient organizations and health charities, researchers, health care professionals and health system decision makers or policy makers;
•Generate preliminary observations, data or knowledge to stimulate research in areas where there is a substantial burden of disease in musculoskeletal conditions and arthritis in Canada, as identified by the respective communities.

The “Catalyst Grant: Addressing Musculoskeletal Conditions and Arthritis in Canadians” is expected to:

• Support original, high quality projects that have the potential to generate innovative research, research tools, techniques, devices, inventions, or methods that will translate into a clinical or health services improvement for Canadians within 5-7 years;
• Facilitate team formation and build patient-oriented research capacity by encouraging partnerships amongst patients, patient communities, patient organizations and health charities, researchers, health care professionals and health system decision makers or policy makers;
• Generate preliminary observations, data or knowledge to stimulate research in areas where there is a substantial burden of disease in musculoskeletal conditions and arthritis in Canada, as identified by the respective communities.

.
• Support knowledge translation to inform practice, clinical care, policy, and/or decision making.
• Build and support partnerships between researchers and health system decision makers.

• The CIHR HIV/AIDS Research Initiative, which is responsible for the management and oversight of the research components of the Federal Initiative to Address HIV/AIDS in Canada, will provide funding for applications that have a primary focus on HIV/AIDS and/or other sexually-transmitted and blood-borne infections (STBBIs) across all CIHR Research Themes (i.e., biomedical research, clinical research, health services research and social, cultural, environmental and population health research).
• Research that focuses on key populations identified by the Federal Initiative to Address HIV/AIDS in Canada is highly encouraged.